^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

SNX20 overexpression

i
Other names: SNX20, Sorting Nexin 20, SLIC1, Selectin Ligand-Interactor Cytoplasmic 1
Entrez ID:
Related biomarkers:
Associations
Trials
over2years
DNA methylation-regulated SNX20 overexpression correlates with poor prognosis, immune cell infiltration, and low-grade glioma progression. (PubMed, Aging (Albany NY))
Depletion of SNX20 significantly inhibits glioma cell proliferation and migration abilities. This is the first study to identify SNX20 as a new potential prognostic biomarker and characterize the functional roles of SNX20 in the progression of LGG, and provides a novel potential diagnostic and therapeutic biomarker for LGG in the future.
Journal • IO biomarker • Epigenetic controller
|
SNX20 (Sorting Nexin 20)
|
SNX20 overexpression
3years
SNX20AR/MiRNA-301a-3p/SNX20 Axis Associated With Cell Proliferation and Immune Infiltration in Lung Adenocarcinoma. (PubMed, Front Mol Biosci)
Our findings suggested that ncRNAs play a crucial role in the regulatory network of SNX20. Collectively, our findings demonstrate the suppressor roles of the SNX20AR/miRNA-301a-3p/SNX20 axis in Lung Adenocarcinoma, represent that SNX20 have the potential of as an effective therapeutic target in future.
Journal
|
SNX20 (Sorting Nexin 20)
|
SNX20 overexpression